Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 39
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Using high-tech toys to improve foraging in captive rhinos

A Foobler is a toy that dispenses food when your pet plays with it. We want to build one for the San Francisco...

Seeking Safer Skies for Haiti's Rarest Seabird

The goal of our research is to reduce collisions of critically endangered Black-Capped Petrel with communication...

Backer Badge Funded